HCA posted revenue of $12.9 billion in the first quarter of this year, up 2.7 percent from the same period a year earlier when revenue totaled $12.5 billion, including $86 million from an arbitration agreement HCA finalized with a payer. The company said same-hospital admissions were up less than 1 percent year over year, while same-facility emergency room visits, inpatient surgeries and outpatient surgeries declined.
“Patient volumes across most services were significantly impacted in the last two weeks of the quarter as various COVID-19 policies were implemented by federal and state governments,” HCA said.
HCA ended the first quarter of this year with net income of $581 million, down 44 percent from $1.04 billion in the same period last year. During the first quarter of 2020, HCA recorded losses of $295 million on retirement of debt and a $7 million gain on the sales of facilities.
In its earnings release, HCA said it has taken several steps to enhance financial and operational flexibility during the COVID-19 pandemic, including cost-reduction initiatives, scaling back capital expenditures, suspending its share repurchase program, executing a new $2 billion loan facility, and requesting accelerated Medicare payments authorized by the Coronavirus Aid, Relief and Economic Security Act.
HCA said COVID-19’s ultimate effect on its financial and operating results this year will depend on several factors, most of which the company is unable to forecast. As a result, HCA is withdrawing its 2020 financial guidance issued in February.
More articles on healthcare finance:
Dispute over testing delays COVID-19 relief package
Banner Health cuts exec pay, plans to furlough up to 7% of employees
COVID-19 financial damage forces West Virginia hospital to close
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
